Frazier Life Sciences logo

Frazier Life Sciences

Investments
44
Lead Investments
19

Frazier Life Sciences IX is a venture capital fund. Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public.

Founded 1991
North America, United States
11-50
frazierhealthcare.com
PitchBook

Highlights

Focus Areas

Biotechnology
Therapeutics
Health Care
Medical
Biopharma

Investment Types

Early Stage Venture
Late Stage Venture
Post-Ipo

Notable Investments

Tubulis logo
Parabilis Medicines logo
Slate Medicines logo
AirNexis Therapeutics logo
Callio Therapeutics logo
Braveheart Bio logo
Bluejay Therapeutics logo
Alentis Therapeutics logo
cAMPfield Therapeutics logo
Metagenomi logo
A
Enliven Therapeutics logo
Carmot Therapeutics logo
Scorpion Therapeutics logo
Aspen Neuroscience logo

Investment History

Team